| Erika Lynn Bendetti, DNP, CRNA | |
|
1925 Pacific Ave, Atlantic City, NJ 08401-6713 | |
| (609) 748-7597 | |
| Not Available |
| Full Name | Erika Lynn Bendetti |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 1925 Pacific Ave, Atlantic City, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285914416 | NPI | - | NPPES |
| AN2817 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 26NR12689500 (New Jersey) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 26NJ00343400 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sg Anesthesia Llc | 3072757079 | 5 |
| Northeast Georgia Anesthesiology Llc | 4385768985 | 4 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Atlanta Hand Specialist Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1285912923 PECOS PAC ID: 5890952410 Enrollment ID: O20120208000844 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Ahs Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316214604 PECOS PAC ID: 7911169925 Enrollment ID: O20120508000359 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Atlanta Anesthesia Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487928370 PECOS PAC ID: 4486818093 Enrollment ID: O20120612000168 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Sg Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053750646 PECOS PAC ID: 3072757079 Enrollment ID: O20130912000589 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Ahs Surgery Center Canton, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1225457948 PECOS PAC ID: 6103043377 Enrollment ID: O20140812000706 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Carpus Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1568864452 PECOS PAC ID: 4688994387 Enrollment ID: O20150520002165 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Radius Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1215302906 PECOS PAC ID: 1456644244 Enrollment ID: O20160802000541 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Ulna Surgery Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1881147965 PECOS PAC ID: 8729356977 Enrollment ID: O20170613001165 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Sleep Ezzy |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154852820 PECOS PAC ID: 4486920295 Enrollment ID: O20171023003067 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Gi Anesthesia Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326569187 PECOS PAC ID: 0446516769 Enrollment ID: O20171102000283 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Jc Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821501206 PECOS PAC ID: 1456614627 Enrollment ID: O20180423000731 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Lotus Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528603925 PECOS PAC ID: 3577990639 Enrollment ID: O20200302001063 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Entity Name | Anesthesia Dynamics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20200508002106 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erika Lynn Bendetti, DNP, CRNA 324 Sea Pine Dr, Egg Harbor Twp, NJ 08234-8127 Ph: (856) 419-9055 | Erika Lynn Bendetti, DNP, CRNA 1925 Pacific Ave, Atlantic City, NJ 08401-6713 Ph: (609) 748-7597 |
News Archive
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
The International Federation of Red Cross and Red Crescent Societies (IFRC) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) launch today, during a side event at the 67th World Health Assembly, a global initiative, called '4 Healthy Habits'.
› Verified 8 days ago
Raymond Daniel Giannascoli Jr., Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-345-4000 | |
Michael Justin Almendras, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 609-449-4345 | |
Michael Joseph Schuman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1925 Pacific Ave, Atlantic City, NJ 08401 Phone: 888-569-1000 |